Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

NCT05827081 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1400

Enrollment

INDUSTRY

Sponsor class

Conditions

Early Breast Cancer

Interventions

DRUG: Ribociclib
DRUG: Letrozole
DRUG: Ansastrozole
DRUG: Goserelin
DRUG: Leuprolide
DRUG: Exemestane

Sponsor

Novartis Pharmaceuticals